NumFin

ZhuZhou QianJin Pharmaceutical Co.,Ltd

Sembol: 600479.SS

SHH

10.91

CNY

Bugünkü piyasa fiyatı

  • 17.9517

    F/K Oranı

  • 0.4616

    PEG Oranı

  • 4.56B

    MRK Kapağı

  • 0.03%

    DIV Verimi

ZhuZhou QianJin Pharmaceutical Co.,Ltd (600479-SS) Finansal Tablolar

Download
YıllıkÜç Aylık
DoğrusalGünlük
Grafikte için dinamiklerde varsayılan sayıları görebilirsiniz ZhuZhou QianJin Pharmaceutical Co.,Ltd (600479.SS). Şirketin geliri NaN M ortalamasını gösterir ki bu da NaN % gowth'dur. Tüm dönem için ortalama brüt kar NaN M olup NaN % dir. Ortalama brüt kar oranı NaN %dır. Şirketin geçen yılki performansı için net gelir artışı NaN % olup NaN % %'ne eşittir. tüm şirket geçmişi için ortalama.,

YıllıkÜç Aylık
10Y20Y30Y40Y

Bilanço

ZhuZhou QianJin Pharmaceutical Co.,Ltd'nın mali yörüngesine baktığımızda, ortalama bir varlık büyümesi gözlemliyoruz. Bu oran, ilginç bir şekilde, şirketin hem en yüksek hem de en düşük seviyelerini yansıtarak olarak gerçekleşiyor. Çeyrekten çeyreğe karşılaştırıldığında, bu rakam olarak ayarlanmaktadır. Geçtiğimiz yıla bakıldığında toplam varlık değişiminin NaN olduğu görülür. Toplam özkaynak ile gösterilen hissedar değeri, raporlama para biriminde NaN olarak değerlenir. Bu açıdan yıldan yıla değişim NaN%'dir.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001

balance-sheet.row.cash-and-short-term-investments

01997.91731.71369.7
1407.6
1378
1100.2
690.3
736.2
544.3
297
205.3
243.2
217.7
334.9
416.9
507.4
527.4
435.8
410.4
383.6
71.3
72.9
93.4

balance-sheet.row.short-term-investments

0-45.7491.7736.8
652.3
-39.6
109.1
182.2
7.8
31.1
69.6
22.1
92.5
98.5
60.3
232
0.2
130
35
6
6.1
0
0
0.2

balance-sheet.row.net-receivables

0967983.9921.6
1164.8
1078.8
972.4
1043
951.2
843.5
876.3
743
610.6
558.1
307.8
260.4
196.8
105.9
113.7
143.4
160.4
113.9
82.8
97.7

balance-sheet.row.inventory

0534.1599547.8
496.8
469.5
440.9
376.3
358.5
272.3
243.2
222.5
195.3
117
126.5
98.8
96.5
82.9
87.3
75.1
84.1
84.9
71
77.5

balance-sheet.row.other-current-assets

015.4198.978.1
120.2
29
82.9
319.7
87.2
267.7
27
5.6
6.7
-29.7
-12.6
-9.8
-12.1
-4.2
-7.1
-8.7
-13.2
-11.6
-13.5
-19.4

balance-sheet.row.total-current-assets

03514.53513.52917.3
3189.3
2955.3
2596.3
2429.2
2133
1927.8
1443.6
1176.4
1055.8
863.1
756.5
766.3
788.6
711.9
629.7
620.1
614.8
258.5
213.1
249.1

balance-sheet.row.property-plant-equipment-net

0589.9622.8630.2
491
478.7
499.8
529.2
565.4
491.4
415.2
396.8
334.6
309.8
285.4
286.7
193.2
153.4
154.6
160
163
150.2
134.7
77.3

balance-sheet.row.goodwill

014.114.114.1
14.1
14.1
14.1
14.1
14.1
14.1
14.1
14.1
8.7
8.7
8.7
8.7
8.7
8.7
0
0
0
0
0
0

balance-sheet.row.intangible-assets

0238.3221.8219.6
216.4
255.2
285.8
241.2
259.8
260.4
247.3
252.8
199.5
45.3
46.5
47.7
47.1
20.2
20.2
4.4
4.6
4.6
4.5
4.6

balance-sheet.row.goodwill-and-intangible-assets

0252.3235.9233.7
230.5
269.3
299.9
255.3
273.9
274.5
261.4
266.9
208.2
54
55.2
56.5
55.8
28.9
20.2
4.4
4.6
4.6
4.5
4.6

balance-sheet.row.long-term-investments

0293.3-304.1-546.1
-462
103
-63.7
-136.8
37.6
4.3
-33.2
14.2
-57.2
-57
-40.5
-86.9
13.4
54
-16.4
3.9
0.5
0
0
0.4

balance-sheet.row.tax-assets

022.76.64.1
4.2
4.2
4.6
6.9
4
3.4
2.5
2.7
1.3
2.1
0.9
0.5
0.5
1.4
0
0
0
0
0
1.3

balance-sheet.row.other-non-current-assets

04.2547.3821
775.7
1.7
135.7
203
18.2
41.9
139.5
31.2
102.4
109.7
71
242.8
7.9
135.6
40.7
9.8
9.7
7.9
7.6
0

balance-sheet.row.total-non-current-assets

01162.41108.51143
1039.4
856.9
876.2
857.6
899.1
815.4
785.4
711.9
589.4
418.6
371.9
499.5
270.8
373.3
199
178.1
177.7
162.8
146.8
83.6

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

04676.946224060.2
4228.7
3812.2
3472.5
3286.9
3032.1
2743.2
2228.9
1888.3
1645.2
1281.7
1128.5
1265.8
1059.4
1085.3
828.7
798.2
792.5
421.3
359.9
332.8

balance-sheet.row.account-payables

0647.5780.9511.7
623
529.1
485.8
469.5
446
317
369.4
168.9
86.1
80.2
80.7
109
91.7
82
81
56.1
69.5
74.6
49.1
77.3

balance-sheet.row.short-term-debt

078.279.588.6
135.9
1.9
1
1
0.5
3.1
61
87
115.9
0
0
131
0
0
0
0
12
33.1
32.8
1.5

balance-sheet.row.tax-payables

070.672.535.6
45.2
41
61.3
67.5
32.9
23.1
41.6
28.4
28.4
34.3
10
15.2
26.6
23.7
23.2
11.3
11.6
18.9
17.1
12.9

balance-sheet.row.long-term-debt-total

038.544.860.3
19.5
20.5
26.7
37.3
47.3
54
32
5.2
0.7
0.7
0.7
0.7
0.7
0.7
0.7
0.7
0.7
0.7
0.7
8.7

Deferred Revenue Non Current

03844.451.3
51.8
42.8
44.4
51.5
50.2
52.9
41.6
44.5
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

069.1705.675.5
84.9
192.3
407.8
130.1
165.4
149.6
125
97.9
76.8
181.3
81.5
19.5
89.4
83.6
85.5
144.7
1.9
5.5
1.6
0.7

balance-sheet.row.total-non-current-liabilities

0108.3108.5131.9
89
81.5
86.6
111.3
111.2
117.6
84.3
55.3
30
26.6
26.5
2.6
2.6
23.7
2.6
2.6
3
3.4
3.4
11.5

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

031.532.844.8
42.5
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

01650.11805.71360.3
1466.7
1182.6
1042.5
1045.7
948.2
779.2
843.2
683.9
581.2
288.1
188.6
314.5
183.7
189.3
169.1
203.4
148.4
188.2
174.3
182.8

balance-sheet.row.preferred-stock

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

0428.9429.8418.5
418.5
418.5
418.5
348.8
348.8
348.8
304.8
304.8
304.8
304.8
304.8
217.7
181.4
151.2
126
84
56
38
38
38

balance-sheet.row.retained-earnings

01142.5970.8930.7
1047.2
959.4
826.1
694.2
568.4
481.4
456.1
414.1
377.7
328.3
328.2
356.9
295.8
260.5
115.5
60.7
122.1
114.1
71.9
57.3

balance-sheet.row.accumulated-other-comprehensive-income-loss

0280.8275.3298.1
298.1
297.2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-total-stockholders-equity

0537.5540.3503
503
503
784.2
834.4
828.5
816.7
360.6
289.3
283.5
275.2
268.6
349.4
374.2
463
399
433.8
452.5
64.8
56
40.1

balance-sheet.row.total-stockholders-equity

02389.72216.22150.4
2266.8
2178.1
2028.8
1877.4
1745.7
1646.8
1121.5
1008.2
966
908.3
901.6
924
851.4
874.6
640.6
578.5
630.6
216.9
165.8
135.4

balance-sheet.row.total-liabilities-and-stockholders-equity

04676.946224060.2
4228.7
3812.2
3472.5
3286.9
3032.1
2743.2
2228.9
1888.3
1645.2
1281.7
1128.5
1265.8
1059.4
1085.3
828.7
798.2
792.5
421.3
359.9
332.8

balance-sheet.row.minority-interest

0637.1600.1549.5
495.2
451.5
401.1
363.8
338.2
317.2
264.3
196.2
98
85.3
38.2
27.3
24.3
21.3
19
16.4
13.5
16.1
19.7
14.5

balance-sheet.row.total-equity

03026.82816.32699.9
2762
2629.6
2430
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.total-liabilities-and-total-equity

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

0247.6187.6190.8
190.3
63.4
45.3
45.3
45.3
35.3
36.3
36.3
35.3
41.6
19.8
145.1
13.6
184
18.6
10
6.5
6.5
5.5
0.5

balance-sheet.row.total-debt

0116.7124.2148.9
155.4
22.4
27.7
38.3
47.8
57.1
93
87
115.9
0.7
0.7
131
0.7
0.7
0.7
0.7
12
33.1
32.8
1.5

balance-sheet.row.net-debt

0-1881.2-1115.7-484
-600
-1355.5
-963.4
-469.8
-680.6
-456.1
-134.4
-96.2
-34.8
-118.5
-274
-53.9
-506.6
-396.7
-400.1
-403.7
-365.5
-38.2
-40.1
-91.7

Nakit Akış Tablosu

ZhuZhou QianJin Pharmaceutical Co.,Ltd'nın mali durumu son dönemde serbest nakit akışında kayda değer bir değişim göstererek NaN şeklinde bir değişim sergilemiştir. Şirket kısa süre önce NaN ihraç ederek sermayesini artırmış ve bir önceki yıla kıyasla NaN oranında bir farka işaret etmiştir. Şirketin yatırım faaliyetleri, raporlama para birimi cinsinden NaN tutarında net nakit kullanımıyla sonuçlanmıştır. Bu, bir önceki yıla göre NaN değişimidir. Aynı dönemde şirket, şirketin yatırım ve geri ödeme stratejilerini anlamada önemli olan NaN, NaN ve NaN 'i kaydetti. Şirketin finansman faaliyetleri NaN net nakit kullanımına yol açmış ve bir önceki yıla göre NaN farkı oluşmuştur. Ayrıca, şirket hissedarlarına temettü ödemeleri için NaN ayırmıştır. Aynı zamanda, NaN olarak adlandırılan ve bu dönemde nakit akışını önemli ölçüde etkileyen başka finansal manevralar da yapmıştır. Bu bileşenler birlikte ele alındığında, şirketin finansal durumu ve nakit akışı yönetimine yönelik stratejik yaklaşımı hakkında kapsamlı bir resim çizmektedir.

common:word.in-mln

USD
Growth
TTM2023202220212020201920182017201620152014201320122011201020092008200720062005200420032002

cash-flows.row.net-income

0395388.3374.7
360.2
352.1
302.6
246.7
173.4
88.3
117.7
128.8
130.9
94.8
97.6
136.9
134.5
176.6
75
61.7
46.6
48.4
38.9

cash-flows.row.depreciation-and-amortization

0103.795.685.9
60.9
61.1
61.8
62.7
50.2
50.4
48.5
48.3
40
38.3
36
25.2
21.8
20.9
24.3
23.3
22
18.3
13.1

cash-flows.row.deferred-income-tax

0-2.8-3.62.7
1.4
-0.9
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.stock-based-compensation

02.83.6-2.7
-1.4
0.9
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.change-in-working-capital

0-81.7246.965.8
129.5
-233
29.3
-11.8
-81.8
-73.8
15.1
-49.5
40.4
-122.7
-81.4
-68.9
-88.6
2.4
47.2
-1.1
-46.4
-19.4
-45.6

cash-flows.row.account-receivables

0-8.7-163.7275.9
27.2
-362.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.inventory

062.3-51.2-52.4
-27.3
-29.1
-64.7
-17.9
-85.5
-29.9
-22.4
-19.8
-78.4
9.6
-27.7
-2
-13.2
3.7
1.7
8.3
1
-13.8
3.1

cash-flows.row.account-payables

0-132.5465.4-160.4
128.2
159.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

0-2.8-3.62.7
1.4
-0.9
94
6.1
3.8
-44
37.4
-29.6
118.8
-132.3
-53.7
-66.8
-75.4
-1.3
45.5
-9.4
-47.4
-5.6
-48.7

cash-flows.row.other-non-cash-items

026.12.7-40.9
-8.2
-24.7
-10.2
-14.1
-0.9
2.6
2.1
10.1
-13.6
12.2
-13
-19.7
-30.4
-120.6
-26.3
-7.5
-3.8
3.6
-0.3

cash-flows.row.net-cash-provided-by-operating-activities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

0-44-34.4-71.9
-97.2
-40.6
-46.4
-57.3
-81.5
-84.5
-66
-84.3
-256.3
-63.9
-58.4
-123.3
-95.3
-22.5
-21.4
-16.7
-56.5
-34
-59.2

cash-flows.row.acquisitions-net

000.230.8
103.6
73
0
13
0.7
85
1.2
-21.4
0.6
1.3
5.8
0.8
0.3
0.8
2.1
0.6
1
0.1
0.2

cash-flows.row.purchases-of-investments

0-402-2102-1570
-2641
-285
-904
-1403.9
-1001.7
-769.6
-405
-135.1
-235.4
-891.1
-565.5
-1545.8
-1482
-576.3
-855.2
-1103.4
-225.3
-1
-5

cash-flows.row.sales-maturities-of-investments

01031.22258.41567.7
1770.3
469.5
1222.9
1006.1
1197.1
605.1
357.6
207.4
266.3
820.6
889.9
1194
1728.4
549.6
845.8
1107.5
219.4
0.5
0.3

cash-flows.row.other-investing-activites

00.100
-97.2
-40.6
2.5
24.3
5.9
-84.5
0.4
0.1
0
-3.9
1.6
2.8
2.8
3.1
2.4
1.8
3.7
2
1.6

cash-flows.row.net-cash-used-for-investing-activites

0585.3122.1-43.3
-961.5
176.3
275
-417.8
120.6
-248.5
-111.8
-33.3
-224.7
-137
273.3
-471.5
154.1
-45.3
-26.3
-10.3
-57.8
-32.5
-62.2

cash-flows.row.debt-repayment

0-50.7-15-127.6
-19.1
-6.2
-10.6
-9.5
-9.3
-105
-147
-180.9
-7.5
-20
-605
-4937
0
-550
-700
-12
-333.7
-39.7
-15.3

cash-flows.row.common-stock-issued

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.common-stock-repurchased

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.dividends-paid

0-147.9-248.6-429.5
-209.3
-167.1
-105
-71.4
-54.4
-66.7
-60.7
-79.9
-61.3
-76.2
-108.9
-59.5
-79.6
-36.4
-96
-28.2
-32.1
-22
-7.7

cash-flows.row.other-financing-activites

0-13.1-0.536.5
124.2
-7.4
-9.1
-12.7
-1.2
620
154.9
180.8
125
55.2
497.8
5065.6
-1.9
548.9
698.6
0.9
711.3
41.7
58.8

cash-flows.row.net-cash-used-provided-by-financing-activities

0-202-264.2-520.6
-104.2
-180.7
-124.7
-93.6
-65
448.4
-52.8
-80
56.2
-41.1
-216.1
69.1
-81.5
-37.4
-97.3
-39.3
345.5
-20
35.8

cash-flows.row.effect-of-forex-changes-on-cash

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.net-change-in-cash

0826.4591.4-78.3
-523.4
151.1
533.7
-227.9
196.4
267.4
18.8
24.3
29.3
-155.4
96.3
-328.9
109.9
-3.4
-3.6
26.9
306.2
-1.5
-20.3

cash-flows.row.cash-at-end-of-period

01928.31101.9510.5
588.8
1112.3
961.2
427.4
655.4
458.9
191.5
172.8
148.5
119.2
274.6
178.4
507.2
397.4
400.8
404.3
377.5
71.3
72.9

cash-flows.row.cash-at-beginning-of-period

01101.9510.5588.8
1112.3
961.2
427.4
655.4
458.9
191.5
172.8
148.5
119.2
274.6
178.4
507.2
397.4
400.8
404.3
377.5
71.3
72.9
93.2

cash-flows.row.operating-cash-flow

0443.1733.5485.6
542.4
155.5
383.5
283.5
140.9
67.5
183.3
137.6
197.8
22.6
39.1
73.5
37.2
79.3
120.1
76.5
18.5
51
6.1

cash-flows.row.capital-expenditure

0-44-34.4-71.9
-97.2
-40.6
-46.4
-57.3
-81.5
-84.5
-66
-84.3
-256.3
-63.9
-58.4
-123.3
-95.3
-22.5
-21.4
-16.7
-56.5
-34
-59.2

cash-flows.row.free-cash-flow

0399.1699413.7
445.1
114.9
337.1
226.2
59.4
-17
117.4
53.4
-58.4
-41.3
-19.3
-49.8
-58.1
56.7
98.7
59.8
-38
16.9
-53.2

Gelir Tablosu Satırı

ZhuZhou QianJin Pharmaceutical Co.,Ltd'nın geliri bir önceki döneme göre NaN% oranında bir değişim gösterdi. Şirketin 600479.SS brüt kârı NaN olarak raporlanmıştır. Şirketin işletme giderleri NaN olup, geçen yıla göre NaN% değişim göstermiştir. Amortisman ve itfa giderleri NaN, yani NaN% son hesap dönemine göre değişimdir. İşletme giderleri NaN olarak raporlanmıştır ve yıldan yıla NaN% değişim göstermektedir. Satış ve pazarlama giderleri NaN, bir önceki yıla göre NaN% değişimdir. Son rakamlara göre FAVÖK NaN olup, yıldan yıla NaN% büyümeyi temsil etmektedir. Faaliyet geliri NaN olup, bir önceki yıla göre NaN% değişim göstermektedir. Net gelirdeki değişim NaN%'dir. Geçen yılın net geliri NaN idi.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001

income-statement-row.row.total-revenue

03798.54026.33663.8
3627
3525.2
3328.6
3182.7
2864.9
2446.7
2194.2
1972.9
1583.4
1256.5
979.4
904.3
801.4
679.8
602.7
665.8
604.9
686.8
582
560.2

income-statement-row.row.cost-of-revenue

02046.72289.92032.2
2030.8
1918.7
1776.3
1743.2
1573.3
1311.5
1141.1
1006.8
786.3
603.5
427.9
360.8
345.8
322.3
309.4
423.8
409.4
476.1
405.9
417.3

income-statement-row.row.gross-profit

01751.81736.41631.6
1596.2
1606.5
1552.3
1439.5
1291.6
1135.2
1053.1
966
797.1
653
551.6
543.4
455.6
357.5
293.3
242
195.5
210.7
176.1
142.9

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

0-3337.9218.6189.1
156.1
147.8
14.9
-9.7
13.6
15
10.5
3.7
0.7
1.6
8.1
1.7
-1.1
0.1
1.2
1.3
1.8
-0.8
-0.9
-2

income-statement-row.row.operating-expenses

03337.91311.71261.1
1224.8
1247.8
1249.1
1170.9
1111.7
1042.9
924.3
810.4
663.7
536.5
474
404.5
345.3
282.9
237.7
178
146.3
142.3
118.1
92.9

income-statement-row.row.cost-and-expenses

03337.93601.53293.4
3255.6
3166.5
3025.4
2914.1
2685
2354.4
2065.4
1817.2
1450
1140.1
901.8
765.3
691
605.2
547.1
601.8
555.7
618.4
524
510.1

income-statement-row.row.interest-income

051.49.811.9
30.4
38.6
20.9
11.7
10.9
4.6
1.2
0.2
1.7
4.1
1.6
0
0
0
2.4
1.8
3.7
1.9
1.6
1.7

income-statement-row.row.interest-expense

01.72.22.1
2.2
0.4
0.7
2.6
2.8
6.5
6.1
4.1
2.1
0.2
0.1
-1
-1.9
0.7
1.1
0.1
1.2
2.3
1.1
0.3

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

0-1.51.6-2.8
0.4
-1.1
49.1
18
26.5
17.3
11.6
-2.8
17.9
-6.8
31.9
17.1
31.4
123.3
27.9
9.1
6.5
1.2
1.3
-0.5

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

0-3337.9218.6189.1
156.1
147.8
14.9
-9.7
13.6
15
10.5
3.7
0.7
1.6
8.1
1.7
-1.1
0.1
1.2
1.3
1.8
-0.8
-0.9
-2

income-statement-row.row.total-operating-expenses

0-1.51.6-2.8
0.4
-1.1
49.1
18
26.5
17.3
11.6
-2.8
17.9
-6.8
31.9
17.1
31.4
123.3
27.9
9.1
6.5
1.2
1.3
-0.5

income-statement-row.row.interest-expense

01.72.22.1
2.2
0.4
0.7
2.6
2.8
6.5
6.1
4.1
2.1
0.2
0.1
-1
-1.9
0.7
1.1
0.1
1.2
2.3
1.1
0.3

income-statement-row.row.depreciation-and-amortization

0103.7104.247.3
60.3
40.8
61.8
62.7
50.2
50.4
48.5
48.3
40
38.3
36
25.2
21.8
20.9
24.3
23.3
22
18.3
13.1
-1.9

income-statement-row.row.ebitda-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

0460.6444.2436.2
424.2
430.8
337.4
296.3
194
94.8
130.4
150
150.9
108.1
101.5
155.2
143.1
198.9
83.9
74.3
55.3
71.5
60.2
51.9

income-statement-row.row.income-before-tax

0459.1445.8433.4
424.6
429.7
352.3
286.6
206.4
109.6
140.4
152.8
151.3
109.7
109.5
156.1
141.8
197.9
84.3
74.3
56.4
70.1
59.3
49.7

income-statement-row.row.income-tax-expense

065.457.658.7
64.4
77.6
49.7
40
33
21.3
22.7
24.1
20.4
14.9
12
19.1
7.3
21.3
9.4
12.6
9.8
21.7
20.3
14.4

income-statement-row.row.net-income

0320.4302.5302.1
297.1
294.3
255.4
207.8
149.4
93
105.1
123.8
120.2
82.8
86.4
130.9
129.9
173.6
71.8
59.9
45.4
50.1
39.8
34.5
Benzer Hisse Senetleri
Bunlar da ilginizi çekebilir:
CHSYF
China Medical System Holdings Limited.
0.9313 USD
PNK
WOCKPHARMA.BO
Wockhardt Limited.
532.5 INR
BSE
185750.KS
Chong Kun Dang Pharmaceutical Corp..
100300 KRW
KSC
ERIS.NS
Eris Lifesciences Limited.
848.1 INR
NSE
300601.SZ
Shenzhen Kangtai Biological Products Co., Ltd..
22.39 CNY
SHZ
TKPHF
Takeda Pharmaceutical Company Limited.
26.83 USD
PNK
MVP.AX
Medical Developments International Limited.
0.61 AUD
ASX
APLLTD.NS
Alembic Pharmaceuticals Limited.
1001.35 INR
NSE
128940.KS
Hanmi Pharm. Co., Ltd..
321500 KRW
KSC
002390.KS
HANDOK Inc..
13700 KRW
KSC

Sıkça Sorulan Sorular

Nedir ZhuZhou QianJin Pharmaceutical Co.,Ltd (600479.SS) toplam varlıklar?

ZhuZhou QianJin Pharmaceutical Co.,Ltd (600479.SS) toplam varlıklar 4676882466.000 şeklindedir.

İşletmenin yıllık geliri nedir?

Yıllık gelir N/A'dur.

Firma kâr marjı nedir?

Firma kar marjı 0.465'dir.

Şirket serbest nakit akışı nedir?

Serbest nakit akışı 1.021'dur.

İşletme net kar marjı nedir?

Net kâr marjı 0.073'dir.

Firma toplam geliri nedir?

Toplam gelir 0.121'dur.

Nedir ZhuZhou QianJin Pharmaceutical Co.,Ltd (600479.SS) net kar (net gelir)?

Net kar (net gelir) 320405834.000'dur.

Firmanın toplam borcu nedir?

Toplam borç 116705915.000'dir.

Faaliyet giderleri rakamı nedir?

İşletme giderleri 3337921320.000'dır.

Şirket nakit rakamı nedir?

İşletme içi nakit 0.000'tir.